首頁 > 市場調查報告書 > 醫療設備

藥物遞輸設備呼吸器

霧化器市場規模、佔有率及成長分析（按類型、模式、應用、最終用戶和地區分類）－2026-2033年產業預測

市場調查報告書

商品編碼

1907487

霧化器市場規模、佔有率及成長分析（按類型、模式、應用、最終用戶和地區分類）－2026-2033年產業預測

Nebulizer Market Size, Share, and Growth Analysis, By Type (Jet, Mesh), By Modality (Portable, Table-top), By Application, By End-use, By Region - Industry Forecast 2026-2033

出版日期: 2025年12月23日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

預計到 2024 年，霧化器市場規模將達到 13.1 億美元，到 2025 年將達到 13.9 億美元，到 2033 年將達到 22.3 億美元，在預測期（2026-2033 年）內，複合年成長率為 6.1%。

霧化器市場正經歷強勁成長，這主要得益於多種因素，包括慢性呼吸系統疾病的增加、居家醫療解決方案需求的成長以及人口老化。尤其是在北美，慢性阻塞性肺病（COPD）因吸煙等不良生活習慣而加劇，是導致死亡的重要因素，因此迫切需要霧化器等有效的呼吸系統護理設備。此外，世界衛生組織（WHO）等國際組織發起的慢性呼吸道疾病防治主導預計將提高診斷率和治療率。隨著醫療保健機構致力於改善呼吸系統疾病管理和預防保健，這些趨勢為霧化器市場帶來了良好的發展前景。

霧化器市場促進因素

包括氣喘、慢性阻塞性肺病（COPD）和囊腫纖維化在內的呼吸系統疾病的日益增多，顯著推動了醫療保健市場對霧化器的需求。這些疾病患者需要有效率、精準地將藥物輸送到呼吸系統，而霧化器正是實現此過程的關鍵設備。霧化器將液體藥物轉化為細霧，使患者能夠直接吸入肺部，從而提高藥物的吸收率和療效。對有效呼吸系統治療日益成長的需求凸顯了霧化器在慢性呼吸系統疾病管理中的重要性，有助於改善患者的整體生活品質。

霧化器市場限制因素

由於與治療相關的報銷政策限制，霧化器市場面臨許多挑戰。保險覆蓋範圍的不一致和報銷限制會阻礙患者獲得霧化器設備和藥物，並影響其經濟承受能力。這些經濟障礙可能會使患者放棄霧化治療，限制市場整體成長。隨著患者越來越難以獲得治療所需的經濟支持，對霧化器的需求可能會下降，進而影響該產業的潛在擴張。這種情況凸顯了審查保險覆蓋政策的必要性，以改善患者的用藥途徑，並促進霧化器市場的發展。

霧化器市場趨勢

霧化器市場正經歷顯著成長，這主要得益於持續的技術創新，這些創新正在重塑產品格局。尤其值得一提的是先進篩孔式噴霧器的出現，這類霧化器採用尖端的振動網技術，能夠產生細密的霧化液，進而提高藥物輸送效率。這些設備不僅體積小巧、便於攜帶，還能減少藥物浪費，因此對患者和醫護人員來說都更具吸引力。此外，呼吸系統疾病的日益增加以及人們對居家醫療解決方案的日益重視，也推動了市場需求的成長，霧化器正穩步成為現代呼吸系統治療方案中不可或缺的一部分。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場參與者所採取的策略
近期市場趨勢
公司市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 依業務板塊進行公司股票分析
- 2023-2025年營收年比比較

主要企業簡介

Omron Corporation（Japan）
Allied Healthcare（United Kingdom）
Teleflex Incorporated（United States）
Briggs Healthcare（United States）
Aerogen（Ireland）
Medtronic Plc（Ireland）
GE Healthcare（United States）
DeVilbiss Healthcare LLC（United States）
Koninklijke Philips NV（Netherlands）
Vectura Group Plc.（United Kingdom）
PARI Respiratory Equipment, Inc.（Germany）
Beurer GmbH（Germany）
Covidien plc（Ireland）
Becton, Dickinson and Company（BD）（United States）
Rossmax International Ltd.（Taiwan）
Nulife Global Medical Devices（India）
BPL Medical Technologies（India）
Agaro（India）
Medline Industries, LP（United States）
Drive DeVilbiss Healthcare（United States）

結論與建議

簡介目錄

Product Code: SQMIG35A2627

Nebulizer Market size was valued at USD 1.31 Billion in 2024 and is poised to grow from USD 1.39 Billion in 2025 to USD 2.23 Billion by 2033, growing at a CAGR of 6.1% during the forecast period (2026-2033).

The nebulizer market is experiencing robust growth driven by several factors, including the rising prevalence of chronic respiratory diseases, increased demand for home healthcare solutions, and a growing aging population. Chronic Obstructive Pulmonary Disease (COPD) is a significant contributor to mortality rates, particularly in North America, where lifestyle choices such as tobacco consumption exacerbate the situation. This highlights an urgent need for effective respiratory management devices like nebulizers. Additionally, global efforts, such as the initiatives led by the World Health Organization to combat chronic respiratory conditions, are projected to enhance diagnosis and treatment rates. These trends signal a promising outlook for the nebulizer market as healthcare providers focus on improving respiratory disease management and preventive care.

Top-down and bottom-up approaches were used to estimate and validate the size of the Nebulizer market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Nebulizer Market Segments Analysis

Global Nebulizer Market is segmented by Type, Modality, Application, End-use and region. Based on Type, the market is segmented into Jet, Mesh and Ultrasonic. Based on Modality, the market is segmented into Portable and Table-top. Based on Application, the market is segmented into COPD, Cystic Fibrosis, Asthma and Others. Based on End-use, the market is segmented into Hospitals And Clinics, Emergency Centers and Home Healthcare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Nebulizer Market

The increasing prevalence of respiratory ailments, including asthma, chronic obstructive pulmonary disease (COPD), and cystic fibrosis, significantly propels the demand for nebulizers in the healthcare market. Patients suffering from these conditions necessitate efficient and targeted delivery of medications to their respiratory systems, and nebulizers are essential devices that facilitate this process. By converting liquid medication into a fine mist, nebulizers enable patients to inhale the treatment directly into their lungs, ensuring enhanced absorption and effectiveness. This growing need for effective respiratory therapies underscores the importance of nebulizers in managing chronic respiratory conditions and improves the overall quality of life for affected individuals.

Restraints in the Nebulizer Market

The nebulizer market faces challenges due to restrictive reimbursement policies associated with nebulizer treatments. Inconsistent coverage and limitations in reimbursement can hinder the affordability and accessibility of nebulizer devices and medications for patients. Such financial barriers may deter individuals from pursuing nebulizer therapy, ultimately constraining the overall growth of the market. As patients encounter difficulties in obtaining necessary financial support for their treatments, the demand for nebulizers may diminish, impacting the industry's potential expansion. This situation necessitates a reevaluation of coverage policies to enhance patient access and facilitate market development in the nebulizer sector.

Market Trends of the Nebulizer Market

The nebulizer market is witnessing a notable upsurge driven by continual technological innovations that are reshaping product offerings. The emergence of advanced mesh nebulizers stands out, as they utilize cutting-edge vibrating mesh technology to create a fine aerosol mist, enhancing medication delivery efficiency. These devices are not only compact and portable but also reduce drug wastage, making them more appealing to both patients and healthcare professionals. Furthermore, the increasing prevalence of respiratory diseases and a growing awareness of home healthcare solutions are contributing to an uptick in demand, positioning nebulizers as a vital component of modern respiratory treatment solutions.

Introduction

Objectives of the Study
Scope of the Report
Definitions

Research Methodology

Information Procurement
Secondary & Primary Data Methods
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Global Market Outlook
Supply & Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Overview
Market Size
Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers

Key Market Insights

Key Success Factors
Degree of Competition
Top Investment Pockets
Market Ecosystem
Market Attractiveness Index, 2025
PESTEL Analysis
Macro-Economic Indicators
Value Chain Analysis
Pricing Analysis

Global Nebulizer Market Size by Type & CAGR (2026-2033)

Market Overview
Jet
Mesh
- Active
- Passive
Ultrasonic

Global Nebulizer Market Size by Modality & CAGR (2026-2033)

Market Overview
Portable
Table-top

Global Nebulizer Market Size by Application & CAGR (2026-2033)

Market Overview
COPD
Cystic Fibrosis
Asthma
Others

Global Nebulizer Market Size by End-use & CAGR (2026-2033)

Market Overview
Hospitals And Clinics
Emergency Centers
Home Healthcare

Global Nebulizer Market Size & CAGR (2026-2033)

North America (Type, Modality, Application, End-use)
- US
- Canada
Europe (Type, Modality, Application, End-use)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Type, Modality, Application, End-use)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Type, Modality, Application, End-use)
- Brazil
- Rest of Latin America
Middle East & Africa (Type, Modality, Application, End-use)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Omron Corporation (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Allied Healthcare (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Teleflex Incorporated (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Briggs Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aerogen (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medtronic Plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
DeVilbiss Healthcare LLC (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Koninklijke Philips N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vectura Group Plc. (United Kingdom)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PARI Respiratory Equipment, Inc. (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Beurer GmbH (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Covidien plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson and Company (BD) (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Rossmax International Ltd. (Taiwan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Nulife Global Medical Devices (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
BPL Medical Technologies (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agaro (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Medline Industries, LP (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Drive DeVilbiss Healthcare (United States)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments